Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026

Get updates on Theralase Technologies Inc. delivered in your email.

Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Timeline

View:

Post by Bunge on Jul 30, 2020 8:49am

Timeline

Better add another year to your timeline.

#VegasParty2030 ?

Level 2 Quote

Level two quotes - Bid
Number of Shares		Bid Price
5,000 shares	5,000	0.195
14,500 shares	14,500	0.190
40,000 shares	40,000	0.185
45,500 shares	45,500	0.180
20,500 shares	20,500	0.175
52,000 shares	52,000	0.170
58,000 shares	58,000	0.165
42,000 shares	42,000	0.160
30,000 shares	30,000	0.155
210,500 shares	210,500	0.150

Level two quotes - Ask
Ask Price	Number of Shares
0.195	5,000	5,000 shares
0.200	39,000	39,000 shares
0.210	27,000	27,000 shares
0.215	20,000	20,000 shares
0.220	39,000	39,000 shares
0.225	26,000	26,000 shares
0.230	51,000	51,000 shares
0.235	10,000	10,000 shares
0.240	21,500	21,500 shares
0.250	131,500

222

Comment

Comment by Quattro74 on Jul 30, 2020 9:39am

Yep, Glad my warrants are good for another 4 years....

109

Comment

Theralase Technologies Inc.

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

Connect with V.TLT

INVESTORS & MEDIA OVERVIEW FINANCIAL FILINGS PRESENTATIONS MEDIA FACT SHEETS MANAGEMENT

Investor Presentation

FACT SHEET

The Watchlist

< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
Best-in-class treatment for NMIBC (according to interim clinical data)
NMIBC (Non-Muscle-Invasive Bladder Cancer)

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250

Become a member today, It's free!

Sign In

Send my password